NVOON

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NameNVOON

RankNo.1496

Market Cap$0.00

Fully Diluted Market Cap$0.00

Market Share%

Trading Vol/Market Cap (24H)2,048.59%

Circulation Supply53,475.04601868

Max Supply0

Total Supply53,475.04601868

Circulation Rate%

Issue Date--

The price at which the asset was first issued--

All-Time High64.27358143874574,2026-01-23

Lowest Price42.278437492782494,2025-11-24

Public BlockchainETH

IntroductionNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Sector

Social Media

• Official Website
• Block Explorer

etfindex:mc_etfindex_sourceDisclaimer: Data provided by cmc and should not be considered as investment advice.